Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colorectal Cancer: Meeting the Challenge

Executive Summary

Early detection of colorectal cancer can dramatically improve an individual's chances for avoiding this deadly disease, and screening colonoscopy is the gold standard for CRC prevention. One detractor, however, is patient avoidance due to perceived discomfort of the bowel preparation process and the colonoscopy itself. Mitigation of these concerns has prompted companies to look for less invasive or even noninvasive screening solutions that have the same sensitivity as diagnostic colonoscopy. These emerging technologies range from advanced endoscopic devices to new methods of in vivo tissue characterization.

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035289

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel